Physician profile
Robert K Kramer
NPI 1346285467
$1,830.62
in general payments reported to CMS, 2019-2025
16 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $298 · 2021: $131 · 2022: $146 · 2023: $407 · 2024: $298 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $306.79 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $284.48 | 2019-2024 | |
| Veryan Medical Incorporated | $269.51 | 2023 | Biomimics 3d Vascular Stent System |
| E.R. Squibb & Sons, L.L.C. | $229.94 | 2020-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $152.44 | 2019-2024 | Xarelto |
| Abbott Laboratories | $119.58 | 2019-2022 | |
| Pfizer INC. | $90.24 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $82.50 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.70 | 2020-2021 | |
| Heartflow, INC. | $49.98 | 2022 | |
| Edwards Lifesciences Corporation | $49.85 | 2020 | |
| Amgen INC. | $45.03 | 2024 | Repatha |
| Novo Nordisk INC | $28.21 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $24.91 | 2023 | Verquvo |
| Cardiovascular Systems INC. | $16.02 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $14.44 | 2024 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.